Preclinical CRO for stem cell, gene therapy, and implantable device development
Neurocore is a preclinical contract research organization focused on regulated therapies in stem cells, gene therapy, and implantable devices for neurological and metabolic conditions. The engineering-heavy hiring footprint and project mix centered on equipment installation, maintenance optimization, and facility upgrades suggest an organization scaling production and GLP compliance infrastructure—consistent with the operational demands of moving preclinical therapies toward clinical evaluation.
Neurocore LLC operates as a preclinical contract research organization based in La Jolla, California, serving biotech and pharma companies developing stem cell therapies, gene therapies, and implantable devices. The company offers integrated services spanning preclinical research, regulatory strategy, toxicology, clinical evaluation, and translational capabilities—the full technical pathway required to move experimental therapies from bench to regulatory submission. Active hiring in engineering and manufacturing, coupled with ongoing facility projects (equipment installation, maintenance programs, site upgrades), indicates scaling of in-house production and testing capacity.
Neurocore is a preclinical CRO specializing in stem cell therapies, gene therapies, and implantable devices for neurodegenerative, neuro-oncologic, and metabolic indications, with integrated preclinical, regulatory, toxicology, and translational capabilities.
Neurocore LLC is headquartered in La Jolla, California, and is actively hiring in the United Kingdom.
Other companies in the same industry, closest in size